2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain
27
Neoplasms
20
Cancer Pain
10
Colonic Neoplasms
7
Breakthrough Pain
7
Agnosia
7
Breast Neoplasms
5
Rectal Neoplasms
4
Prostatic Neoplasms
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Chronic Pain
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Pain, Postoperative
3
Lymphoma, Follicular
3
Breakthrough Cancer Pain
3
Waldenstrom Macroglobulinemia
2
Uterine Cervical Neoplasms
2
Thrombocythemia, Essential
2
Sezary Syndrome
2
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Pleural Effusion, Malignant
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Myeloproliferative Disorders
2
Mycosis Fungoides
2
Interventions
esmolol
1
Polyamines
1
Fentanyl
1
Amantadine
1
Adrenergic beta-Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hyperalgesia
×
Fentanyl
×
Clear all
NCT01544959
2018-10-24
PAINFree
Université de Sherbrooke
Phase NA
Completed
84 enrolled